Drug Profile


Alternative Names: AC-223; Artes

Latest Information Update: 04 Aug 2004

Price : $50

At a glance

  • Originator Sumitomo Pharmaceuticals
  • Class Antihyperlipidaemics; Unsaturated fatty acids
  • Mechanism of Action Sterol O-acyltransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Hypercholesterolaemia

Most Recent Events

  • 04 Aug 2004 Withdrawn for Hypercholesterolaemia in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top